FI921428A0 - Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor. - Google Patents

Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor.

Info

Publication number
FI921428A0
FI921428A0 FI921428A FI921428A FI921428A0 FI 921428 A0 FI921428 A0 FI 921428A0 FI 921428 A FI921428 A FI 921428A FI 921428 A FI921428 A FI 921428A FI 921428 A0 FI921428 A0 FI 921428A0
Authority
FI
Finland
Prior art keywords
bfgf
thr
fibroblastvaextfaktor
enzymatisk
basisk
Prior art date
Application number
FI921428A
Other languages
English (en)
Other versions
FI921428A (fi
Inventor
Pierre Monsan
Francois Paul
Didier Betbeder
Paolo Sarmientos
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI921428A publication Critical patent/FI921428A/fi
Publication of FI921428A0 publication Critical patent/FI921428A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI921428A 1990-08-02 1992-04-01 Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor. FI921428A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor
PCT/EP1991/001428 WO1992002539A1 (en) 1990-08-02 1991-07-30 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (2)

Publication Number Publication Date
FI921428A FI921428A (fi) 1992-04-01
FI921428A0 true FI921428A0 (fi) 1992-04-01

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921428A FI921428A0 (fi) 1990-08-02 1992-04-01 Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor.

Country Status (27)

Country Link
US (1) US5348863A (fi)
EP (1) EP0495049B1 (fi)
JP (1) JPH05501655A (fi)
KR (1) KR100191697B1 (fi)
CN (1) CN1033810C (fi)
AT (1) ATE152122T1 (fi)
AU (1) AU643822B2 (fi)
CA (1) CA2066174A1 (fi)
CZ (1) CZ286237B6 (fi)
DE (1) DE69125810T2 (fi)
DK (1) DK0495049T3 (fi)
ES (1) ES2103822T3 (fi)
FI (1) FI921428A0 (fi)
GB (1) GB9017008D0 (fi)
GR (1) GR3024111T3 (fi)
HU (1) HU212671B (fi)
IE (1) IE912729A1 (fi)
IL (1) IL98988A (fi)
MY (1) MY107334A (fi)
NO (1) NO301480B1 (fi)
NZ (1) NZ239204A (fi)
PH (1) PH31240A (fi)
PT (1) PT98544B (fi)
RU (1) RU2093519C1 (fi)
WO (1) WO1992002539A1 (fi)
YU (1) YU48309B (fi)
ZA (1) ZA916026B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659723B2 (en) * 1992-02-14 1995-05-25 Kaken Pharmaceutical Co., Ltd. Remedy for airway diseases
NZ284434A (en) * 1994-04-21 1998-12-23 Novo Nordisk As Use of heparin binding protein to prevent lps-induced cytokine cascade during sepsis
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
PT1583562E (pt) 2003-01-06 2011-09-19 Angiochem Inc Angiopep-1, compostos relacionados, e suas utilizações
KR20050100616A (ko) 2003-01-14 2005-10-19 테바 파마슈티컬 인더스트리즈 리미티드 전신성 홍반성 낭창의 치료를 위한 펩티드의 비경구 제제
CA2607113C (en) 2004-05-05 2013-11-12 Valorisation-Recherche, Societe En Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
JP2008542685A (ja) 2005-05-05 2008-11-27 ヴァロリザーシヨン・アッシュエスジ,ソシエテ・アン・コマンディット サイトカイン受容体修飾因子及びその使用
CA2688344C (en) 2007-05-29 2019-09-03 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
EP2279008B1 (en) 2008-04-18 2019-03-06 Angiochem Inc. Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
JP2012505637A (ja) 2008-10-15 2012-03-08 アンジオケム,インコーポレーテッド Glp−1アゴニストのコンジュゲート及びその使用
AU2009304505A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
CN102307904A (zh) 2008-12-05 2012-01-04 安吉奥开米公司 神经降压素或神经降压素类似物的缀合物及其用途
CN102300987A (zh) 2008-12-17 2011-12-28 安吉奥开米公司 膜型-1基质金属蛋白抑制剂及其用途
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
EP2588490B1 (en) 2010-07-02 2017-02-22 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
WO2014185858A1 (en) * 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
JP6709217B2 (ja) 2014-11-19 2020-06-10 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 皮膚の修復および/または再生において使用するためのヘパラン硫酸
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
ES2826827T3 (es) 2015-06-15 2021-05-19 Angiochem Inc Métodos para el tratamiento de carcinomatosis leptomeníngea
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
IE912729A1 (en) 1992-02-12
GR3024111T3 (en) 1997-10-31
RU2093519C1 (ru) 1997-10-20
CA2066174A1 (en) 1992-02-03
DE69125810T2 (de) 1997-08-07
NO921236D0 (no) 1992-03-30
HU9201101D0 (en) 1992-08-28
PT98544A (pt) 1992-06-30
AU8304491A (en) 1992-03-02
NO301480B1 (no) 1997-11-03
ZA916026B (en) 1992-04-29
PT98544B (pt) 1999-01-29
NZ239204A (en) 1993-11-25
IL98988A (en) 1997-02-18
WO1992002539A1 (en) 1992-02-20
FI921428A (fi) 1992-04-01
YU131991A (sh) 1994-05-10
DE69125810D1 (de) 1997-05-28
PH31240A (en) 1998-06-18
YU48309B (sh) 1998-05-15
NO921236L (no) 1992-03-30
CS236291A3 (en) 1992-02-19
KR920702371A (ko) 1992-09-03
CN1033810C (zh) 1997-01-15
GB9017008D0 (en) 1990-09-19
HUT64564A (en) 1994-01-28
ES2103822T3 (es) 1997-10-01
CZ286237B6 (cs) 2000-02-16
DK0495049T3 (da) 1997-08-25
IL98988A0 (en) 1992-07-15
JPH05501655A (ja) 1993-04-02
KR100191697B1 (ko) 1999-06-15
US5348863A (en) 1994-09-20
ATE152122T1 (de) 1997-05-15
MY107334A (en) 1995-11-30
EP0495049A1 (en) 1992-07-22
CN1058597A (zh) 1992-02-12
AU643822B2 (en) 1993-11-25
HU212671B (en) 1996-09-30
EP0495049B1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
FI921428A (fi) Process foer enzymatisk framstaellning av en basisk fibroblastvaextfaktor.
DE69132318D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE69322545D1 (de) Verfahren zur Herstellung von Endlosfasern durch mechanisches Ziehen
DE59409751D1 (de) Verfahren zur Herstellung von hydroxyphenylsubstituierten 1,3,5-Triazinen
DE69122936D1 (de) Verfahren zur Herstellung von Sialsäure
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
DE69021711D1 (de) Verfahren zur Herstellung von optisch aktiven Hydroxylactonen.
ATE101144T1 (de) Verfahren zur herstellung von cyclischen sulfaten.
DE59003697D1 (de) Verfahren zur Herstellung von Chromsäure.
DE69133173D1 (de) Verfahren zur Herstellung von Knollen
DE69403537D1 (de) Verfahren zur Synthese von halbsynthetischen Glykosaminoglykanen mit Heparin- oder Heparanstruktur, die in 2-Position modifiziertes Alpha-L-Iduronsäure-2-O-Sulfat enthalten
DE69313470D1 (de) Verfahren zur Herstellung von Multifilamenten
DE59408417D1 (de) Verfahren zur Herstellung von substituierten Chinazolin-2,4-dionen
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE69003888D1 (de) Verfahren zur Herstellung von Haloalkylalkanoaten.
IT9045744A0 (it) Procedimento per la fabbricazione di rivestimenti decorativi per i mobili d'arredamento
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
DE69106617D1 (de) Verfahren zur Herstellung von Dihydroxybenzolen.
DE69111082D1 (de) Verfahren zur Herstellung von festen Betainen.
DE69011335D1 (de) Verfahren zur Herstellung von geformten Gegenständen.
DE59101638D1 (de) Verfahren zur Herstellung von Alkaliphosphatlösungen.
TH39843A (th) อะนาลอคของโทโมซิน อัลฟา1